Ra Capital Management, L.P. Nkarta, Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Nkarta, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,805,129 shares of NKTX stock, worth $27.3 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
10,805,129
Previous 10,805,129
-0.0%
Holding current value
$27.3 Million
Previous $63.9 Million
23.52%
% of portfolio
0.68%
Previous 0.96%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
129Shares Held
66.5MCall Options Held
173KPut Options Held
20K-
Commodore Capital LP New York, NY4.66MShares$11.8 Million1.79% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$10.3 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.03MShares$10.2 Million0.97% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$9.53 Million9.87% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.6MShares$9.11 Million0.03% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $123M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...